1Department of Internal Medicine, Catholic University of Daegu School of Medicine, Daegu, Korea.
2Department of Obstetrics and Gynecology, Catholic University of Daegu School of Medicine, Daegu, Korea.
Copyright © 2017 Korean Diabetes Association
This is an Open Access article distributed under the terms of the Creative Commons Attribution Non-Commercial License (http://creativecommons.org/licenses/by-nc/4.0/) which permits unrestricted non-commercial use, distribution, and reproduction in any medium, provided the original work is properly cited.
CONFLICTS OF INTEREST: No potential conflict of interest relevant to this article was reported.
Values are presented as mean±standard deviation or number (%).
BMI, body mass index; HbA1c, glycosylated hemoglobin; HDL-C, high density lipoprotein cholesterol; LDL-C, low density lipoprotein cholesterol; HOMA-IR, homeostasis model assessment of insulin resistance; HOMA2-%B, homeostasis model assessment of insulin resistance 2-%B; HOMA2-%S, homeostasis model assessment of insulin resistance 2-%S; GDM, gestational diabetes mellitus; Hx, history.
aDuring pregnancy at screening for GDM.
Values are presented as mean±standard deviation, median (range), or number (%).
BMI, body mass index; GDM, gestational diabetes mellitus; HbA1c, glycosylated hemoglobin; HDL-C, high density lipoprotein cholesterol; LDL-C, low density lipoprotein cholesterol; HOMA-IR, homeostasis model assessment of insulin resistance; HOMA2-%B, homeostasis model assessment of insulin resistance 2-%B; HOMA2-%S, homeostasis model assessment of insulin resistance 2-%S; Hx, history.
aP<0.05, bDuring pregnancy at screening for GDM.
Values are presented as mean±standard deviation, median (range), or number (%).
BMI, body mass index; GDM, gestational diabetes mellitus; HbA1c, glycosylated hemoglobin; HDL-C, high density lipoprotein cholesterol; LDL-C, low density lipoprotein cholesterol; HOMA-IR, homeostasis model assessment of insulin resistance; HOMA2-%B, homeostasis model assessment of insulin resistance 2-%B; HOMA2-%S, homeostasis model assessment of insulin resistance 2-%S; Hx, history.
aP<0.05, bDuring pregnancy at screening for GDM.
Values are presented as mean±standard deviation or number (%).
GDM, gestational diabetes mellitus; BMI, body mass index; HbA1c, glycosylated hemoglobin; HDL-C, high density lipoprotein cholesterol; LDL-C, low density lipoprotein cholesterol; HOMA-IR, homeostasis model assessment of insulin resistance; HOMA2-%B, homeostasis model assessment of insulin resistance 2-%B; HOMA2-%S, homeostasis model assessment of insulin resistance 2-%S; Hx, history.
aRecommended range, bKruskal-Wallis test, cP<0.05, dDuring pregnancy at screening for GDM.
HOMA-IR, homeostasis model assessment of insulin resistance; BMI, body mass index; GDM, gestational diabetes mellitus; HOMA2-%B, homeostasis model assessment of insulin resistance 2-%B; HOMA2-%S, homeostasis model assessment of insulin resistance 2-%S.
aSpearman's correlation, bP<0.05, cDuring pregnancy at screening for GDM.